5-hydroxytryptamine receptor 3A — Drug Target

All drugs that target 5-hydroxytryptamine receptor 3A — marketed and clinical-stage. Includes 6 drug classes acting on this target.

Drug classes

tropisetron · Serotonin-3 Receptor Antagonist · Amide Local Anesthetic [EPC] · aurothioglucose · azasetron · indisetron

Marketed (5)

• Navoban · tropisetron · Metabolic
• Lotronex · Legacy Pharma · Serotonin-3 Receptor Antagonist · Neuroscience
  Lotronex works by blocking serotonin receptors in the gut to slow down bowel movements.
• Isocain · Pfizer · Amide Local Anesthetic [EPC] · Pain
• Aureotan · aurothioglucose · Immunology
• Anzemet · Validus Pharms · Serotonin-3 Receptor Antagonist · Other

Phase 2 pipeline (2)

• Nazasetron · azasetron · Other
  Nazasetron works by binding to the 5-hydroxytryptamine receptor 3A, blocking its action and reducing symptoms.
• Sinseron · indisetron · Neuroscience
  Sinseron works by binding to the 5-hydroxytryptamine receptor 3A, which is involved in various physiological processes.